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Background: Paroxysmal and persistent atrial fibrillation (AF) is common clinical problem for patients with atrial septal defect (ASD). Recently, 
pulmonary vein isolation (PVI) for AF and transcatheter ASD closure has been available. However, effectiveness of hybrid approach involving PVI and 
device closure of ASD for patients with paroxysmal and persistent AF is unknown.
Methods: Between June 2009 and September 2010, 125 patients with secundum ASD were scheduled for transcatheter ASD closure using 
Amplatzer septal occluder. Eight patients (mean age 48±14 years) out of all who were documented paroxysmal (n=6) and persistent AF (n=2) before 
ASD closure underwent PVI, and transcatheter ASD closure was performed 3 months after PVI.
Results: Maximal ASD diameter was 18.4±3.3mm. In electrophysiologic study, low voltage area was observed both in left and right atria, and 
PVI was successfully performed in all patients without any complications. Recurrence of AF occurred in two patients within 3 months after single-
procedure, and re-PVI including superior vena cava isolation (n=1) contributed to sinus rhythm conversion. Transcatheter ASD closure successfully 
perfomed in all using 22.3±3.6mm device. All patients were free from AF after ASD closure without antiarrhythmic drugs during follow up 
(6.5±4.3months).
Conclusions: Hybrid approach involving PVI and transcatheter ASD closure will become the novel therapeutic option in symptomatic patients with 
paroxysmal and persistent AF.
